Neuronal and immunological basis of action of antidepressants in chronic pain-clinical and experimental studies

Pharmacological Reports

Volumn 65, Issue 6, 2013, Pages 1611-1621

  Mika, Joanna ^a   Zychowska, Magdalena ^a   Makuch, Wioletta ^a   Rojewska, Ewelina ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Chronic pain; Neuropathy

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; DESIPRAMINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GABAPENTIN; IMIPRAMINE; MAPROTILINE; MILNACIPRAN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ANALGESIA; ANXIETY DISORDER; CANCER PAIN; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CONSTIPATION; DEPRESSION; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; FACE PAIN; FIBROMYALGIA; HEADACHE; HUMAN; IMMUNE RESPONSE; INSOMNIA; LOW BACK PAIN; LOW DRUG DOSE; MAJOR DEPRESSION; MICTURITION DISORDER; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; POSTHERPETIC NEURALGIA; REVIEW; SEDATION; SEXUAL DYSFUNCTION; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC PAIN; HUMANS;

EID: 84894153268     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71522-6     Document Type: Article

References (63)

1. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr: A randomized, placebo-controlled, doubleblind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med, 2002, 112, 191-197.
2. Attal N, Gaudé V, Brasseur L, Dupuy M, Guirimand F, Parker F, Bouhassira D: Intravenous lidocaine in central pain: A double-blind, placebo-controlled, psychophysical study. Neurology, 2000, 54, 564-574. (Pubitemid 30082919)
3. Baldessarini RJ: Drugs for the treatment of psychiatric disorders. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th edn., Eds. Hardman JG, Limbird LE, McGraw Hill, New York, USA, 2001, 447-483.
4. Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P: Amitriptyline vs. pregabalin in painful diabetic neuropathy: A randomized double blind clinical trial. Diabet Med, 2009, 26, 1019-1026.
5. Basterzi AD, Aydemir C. Kisa C: IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol, 2005, 20, 473-476. (Pubitemid 41489458)
6. Benbouzid M, Gavériaux-Ruff C, Yalcin I, Waltisperger E, Tessier LH, Muller A, Kieffer BL et al.: Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry, 2008, 63, 633-636. (Pubitemid 351273190)
7. Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L, Alkis N: Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Support Care Cancer, 2008, 16, 1291-1298.
8. de Boer T: The pharmacologic profile of mirtazapine. J Clin Psychiatry, 1996, 57, Suppl 4, 19-25. (Pubitemid 26177340)
9. Deffois A, Fage D, Carter C: Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett, 1996, 220, 117-1120.
10. Dhillon S: Duloxetine: A review of its use in the management of major depressive disorder in older adults. Drugs Aging, 2013, 30, 59-79.
11. Eardley W, Toth C: An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy. J Pain Res, 2010, 3, 33-49.
12. Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD: Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacol Bull, 1990, 26, 311-315. (Pubitemid 20386901)
13. Ferguson JM: SSRI antidepressant medications: Adverse effects and tolerability. Prim Care Companion J Clin Psychiatry, 2001, 3, 22-27. (Pubitemid 33807486)
14. Finnerup NB, Biering-Sørensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH et al.: Intravenous lidocaine relieves spinal cord injury pain: A randomized controlled trial. Anesthesiology, 2005, 102, 1023-1030. (Pubitemid 40586545)
15. Fryer JD, Lukas RJ: Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J Neurochem, 1999, 72, 1117-1124. (Pubitemid 29085026)
16. Galer BS: Neuropathic pain of peripheral origin: Advances in pharmacologic treatment. Neurology, 1995, 45, Suppl 9, S17-25. (Pubitemid 26156628)
17. Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, Williams DA et al.: Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol, 2005, 32,1975-1985. (Pubitemid 41429029)
18. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain, 2005, 116, 109-118. (Pubitemid 40828506)
19. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT et al.: Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain, 2002, 98, 195-203. (Pubitemid 34722482)
20. Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ: Time course of depression-symptom improvement during treatment with duloxetine. Depress Anxiety, 2005, 21, 170-177. (Pubitemid 41170386)
21. Ignatowski TA, Sud R, Reynolds JL, Knight PR, Spengler RN: The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-alpha (TNF). Neuropharmacology, 2005, 48, 448-460. (Pubitemid 40250008)
22. Jain R, Jain S: Anti-depressants in the treatment of chronic pain. Pract Pain Manag, 2011, 44-50.
23. Jasmin L, Tien D, Janni G, Ohara P: Is noradrenaline a significant factor in the analgesic effect of antidepressants? Pain, 2003, 106, 3-8. (Pubitemid 37329607)
24. Khalifa M, Daleau P, Turgeon J: Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther, 1999, 291, 280-284. (Pubitemid 29451600)
25. Korzeniewska-Rybicka I, Panik A: Analgesic effect of antidepressant drugs. Pharmacol Biochem Behav, 1998, 59, 331-338. (Pubitemid 28072725)
26. Kvinesdal B, Molin J, Froland A, Gram LF: Imipramine treatment of painful diabetic neuropathy. J. Amer. Med. Assoc, 1984, 251, 1727-1730. (Pubitemid 14174179)
27. Leijon G, Boivie J: Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine. Pain, 1989, 36, 27-36. (Pubitemid 19024963)
28. Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK: Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: A case series and review of the literature. J ECT, 2011, 27, 165-167.
29. Mattia C, Paoletti F, Coluzzi F, Boanelli A: New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol, 2002, 68, 105-114. (Pubitemid 41739203)
30. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New Engl J Med, 1992, 326, 1250-1256.
31. Mazza M, Mazza O, Pazzaglia C, Padua L, Mazza S: Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother, 2010, 11, 1049-1052.
32. McCleane G: Antidepressants as analgesics. CNS Drugs, 2008, 22, 139-156.
33. Micó JA, Ardid D, Berrocoso E, Eschalier A: Antidepressants and pain. Trends Pharmacol Sci, 2006, 27, 348-354. (Pubitemid 43963184)
34. Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B: Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol, 2009, 623, 65-72.
35. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B: Importance of glial activation in neuropathic pain. Eur J Pharmacol, 2013, 716, 106-119.
36. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ: Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev, 2012, 12, CD008242.
37. Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ: Diurnal mood variation in outpatients with major depressive disorder. Depress Anxiety, 2009, 26, 851-863.
38. Nørregaard J, Volkmann H, Danneskiold-Samsøe B: A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain, 1995, 61, 445-449.
39. Onishi H, Yamamoto W, Wada M, Nishida T, Wada M, Sunagawa Y, Miya T et al.: Detection and treatment of akathisia in advanced cancer patients during adjuvant analgesic therapy with tricyclic antidepressants: Case reports and review of the literature. Palliat Support Care, 2007, 5, 411-414.
40. Pick CG, Paul D, Eison MS, Pasternak GW: Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol, 1992, 211, 375-381.
41. Rasmussen PV, Jensen TS, Sindrup SH, Bach FW: TDM-based imipramine treatment in neuropathic pain. Ther Drug Monit, 2004, 26, 352-360. (Pubitemid 38989653)
42. Rowbotham DJ: Neuropathic pain and quality of life. Eur J Pain, 2002, 6, Suppl B, 19-24. (Pubitemid 35177616)
43. Ryder SA, Stannard CF: Treatment of chronic pain: Antidepressant, antiepileptic and antiarrhythmic drugs. Contin Educ Anaesth Crit Care Pain, 2005, 5, 18-21. (Pubitemid 41219044)
44. Semenchuck MR, Sherman S, Davis B: Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology, 2001, 57, 1583-1588. (Pubitemid 33055474)
45. Shah TH, Moradimehr A: Bupropion for the treatment of neuropathic pain. Am J Hosp Palliat Care, 27, 333-336.
46. Simpson DA: Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis, 2001, 3, 53-62. (Pubitemid 33130299)
47. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action Pain, 1999, 83, 389-400.
48. Sindrup SH, Otto M, Finnerup NB, Jensen TS: Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol, 2005, 96, 399-409. (Pubitemid 40835693)
49. Smith AJ: The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol, 1998, 12, 407-413. (Pubitemid 28561447)
50. Stahl SM, Grady MM, Moret C, Briley M: SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr, 2005, 10, 732-747. (Pubitemid 41443048)
51. Stokes PE: Fluoxetine: A five years review. Clin Ther, 1993, 15, 216-243.
52. Suter MR, Kirschmann G, Laedermann CJ, Abriel H, Decosterd I: Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state. Anesthesiology, 2013, 118, 160-172.
53. Tzschentke TM, Christoph T, Schröder W, Englberger W, De Vry J, Jahnel U, Kögel BY: Tapentadol: With two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview. Schmerz, 2011, 25, 19-25.
54. Verdu B, Decosterd I, Buclin T, Stiefel F, Berney A: Antidepressants for the treatment of chronic pain. Drugs, 2008, 68, 2611-2632.
55. Vickers ER, Cousins MJ: Neuropathic orofacial pain. Part 2-Diagnostic procedures, treatment guidelines and case reports. Aust Endod J, 2000, 26, 53-63.
56. Watkins LR, Hutchinson MR, Johnston IN, Maier SF: Glia: Novel counter-regulators of opioid analgesia. Trends Neurosci, 2005, 28, 661-669. (Pubitemid 41654390)
57. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N: Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossovertrial. Pain, 1991, 48, 29-36.
58. Wong DT, Bymaster FP: Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype? Prog Drug Res, 2002, 58, 169-222. (Pubitemid 34464546)
59. Wrzosek A, Obara I, Wordliczek J, Przewlocka B: Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: An isobolographic analysis. J Physiol Pharmacol, 2009, 60, 71-78.
60. Zhu J, Wei X, Feng X, Song J, Hu Y, Xu J: Repeated administration of mirtazapine inhibits development of hyperalgesia/ allodynia and activation of NF-kB in a rat model of neuropathic pain. Neurosci Lett, 2008, 433, 33-37.
61. Zhu J, Wei X, Liu J, Hu Y, Xu J: Interaction of glia activation and neurotransmission in hippocampus of neuropathic rats treated with mirtazapine. Exp Clin Psychopharmacol, 2009, 17, 198-203.
62. Ziegler D: Painful diabetic neuropathy: Advantage of novel drugs over old drugs? Diabetes Care, 2009, 32, Suppl 2, S414-S419.
63. Ziegler D: Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metab Res Rev, 2008, 24, Suppl 1, S52-S57. (Pubitemid 351802772)